|Continuum Health Partners: Beth Israel • Roosevelt Hospital and St. Luke's Hospital • Long Island College Hospital • New York Eye and Ear Infirmary|
|Home | Find A Doctor | Contact Us|
Proleukin® Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
The PROCLAIM Registry, is designed to create an observational database that will allow evaluations of the real world treatment patterns and trends involving High dose IL-2 effectiveness, tolerability, and other patient management outcomes in treating patients with metastatic renal cell carcinoma, metastatic melanoma or other malignancies in the United States.
The primary objective is to establish a standardized source of observational
data that can be used to report and query patient care patterns, clinical
outcomes and trends from HD IL-2 therapy in treating metastatic melanoma,
metastatic renal cell carcinoma or other malignancies.
Please call for more information.
Copyright © 2008